Kevin Nishimoto

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Amani Makkouk, Xue Yang, Taylor Barca et al. · Journal for ImmunoTherapy of Cancer · 2021 · 171 citations · Full text

Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail

Edward L. Nelson, Lari Wenzel, Kathryn Osann et al. · Clinical Cancer Research · 2008 · 134 citations · Full text

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

H. Jean Khoury, Robert H. Collins, William Blum et al. · Cancer · 2017 · 104 citations · Full text

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Kevin Nishimoto, Taylor Barca, Aruna Azameera et al. · Clinical & Translational Immunology · 2022 · 100 citations · Full text

Generation of Immunogenic Dendritic Cells from Human Embryonic Stem Cells without Serum and Feeder Cells

Su-Yi Tseng, Kevin Nishimoto, Kathryn M. Silk et al. · Regenerative Medicine · 2009 · 58 citations